The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMGP.L Regulatory News (MGP)

  • There is currently no data for MGP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/NON-RI) Medica Group Plc

4 Jul 2023 10:58

RNS Number : 9270E
Jefferies International Limited.
04 July 2023
 

FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Jefferies International Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Medica Group plc

(c) Name of the party to the offer with which exempt principal trader is connected:

IK Investment Partners Limited

(d) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

3rd July 2023

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

0.2p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

3,771,214

3.06

 

 

(2) Cash-settled derivatives:

 

 

 

3,771,214

3.06

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

3,771,214

3.06

3,771,214

3.06

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

0.2p ordinary

 

Purchase

 

406,000

 

 

211.1055 GBX

 

 

211.1055 GBX

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

0.2p ordinary

Swap

Increasing a short position

406,000

211.1055

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

4th July 2023

Contact name:

Zara Watters

Telephone number:

020 7029 8661

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEOGCGDRUUGDGXS
Date   Source Headline
1st Aug 20225:33 pmRNSHolding(s) in Company
1st Aug 20222:58 pmRNSIssue of Equity and Total Voting Rights
1st Aug 202212:13 pmRNSHolding(s) in Company
26th Jul 20227:00 amRNSTrading update and full year outlook
25th Jul 20222:30 pmRNSHolding(s) in Company
30th Jun 20227:00 amRNSBlock Listing Application
28th Jun 202212:46 pmRNSHolding(s) in Company
27th Jun 20221:58 pmRNSResult of AGM
27th Jun 20227:00 amRNSAGM Statement
27th May 20225:22 pmRNSNotice of AGM
19th May 20227:00 amRNSHolding(s) in Company
12th Apr 202211:29 amRNSPublication of Annual Report
4th Apr 20227:00 amRNSResults for the year ended 31 December 2021
9th Mar 20224:40 pmRNSSecond Price Monitoring Extn
9th Mar 20224:35 pmRNSPrice Monitoring Extension
3rd Mar 20224:35 pmRNSPrice Monitoring Extension
16th Feb 202211:22 amRNSHolding(s) in Company
4th Feb 20223:05 pmRNSNotification of Major Holdings
28th Jan 20222:02 pmRNSNotification of Major Holdings
27th Jan 20221:19 pmRNSNotification of Major Shareholdings
26th Jan 20227:00 amRNSTrading and Business Update
24th Jan 20228:00 amRNSHolding(s) in Company
7th Jan 20227:00 amRNSAppointment of Numis as Joint Broker
5th Jan 20223:21 pmRNSBlock listing Interim Review
30th Dec 20213:48 pmRNSIssue of Equity
20th Dec 20214:36 pmRNSPrice Monitoring Extension
20th Dec 20218:00 amRNSHolding(s) in Company
25th Nov 20218:00 amRNSHolding(s) in Company
2nd Nov 202110:01 amRNSDirector/PDMR Shareholding
29th Oct 20219:18 amRNSTotal Voting Rights
8th Oct 20217:00 amRNSIssue of Equity
29th Sep 20217:00 amRNSRecord Date for Dividend – Correction
27th Sep 20217:00 amRNSInterim results for the six months to 30 June 2021
17th Sep 20211:47 pmRNSHolding(s) in Company
7th Sep 20217:00 amRNSCapital Markets Day
26th Aug 202110:17 amRNSHolding(s) in Company
17th Aug 202111:20 amRNSHolding(s) in Company
30th Jul 20217:00 amRNSIssue of Equity and Total Voting Rights
22nd Jul 20217:00 amRNSTrading and business update
8th Jul 20219:28 amRNSHolding(s) in Company
5th Jul 202110:49 amRNSBlock Listing Application
22nd Jun 20211:45 pmRNSDirector/PDMR Shareholding
21st Jun 20217:00 amRNSDirector/PDMR Shareholding
16th Jun 20211:00 pmRNSResult of AGM
16th Jun 20217:00 amRNSAGM Statement
15th Jun 20217:40 amRNSDirector Declaration
15th Jun 20217:00 amRNSMedica appoints Barbara Moorhouse as NED
11th Jun 20214:34 pmRNSDirector/PDMR Shareholding
9th Jun 20219:05 amRNSHolding(s) in Company
4th Jun 20211:42 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.